参考文献/References:
[1] 孙延娟,杨宗强,孙延龙.肝硬化患者肺部感染的相关因素分析[J].中国病原生物学杂志,2017,12(1):76-78.
Sun YJ,Yang ZQ,Sun YL.Analysis of factors related to developmentof a pulmonary infection in patients with liver cirrhosis[J].Journal of Pathogen Biology,2017,12(1):76-78.
[2] 郑俊福,蔡照华,张 鑫,等.降钙素原和外周血白细胞/血小板单独或联合检测对肝硬化合并细菌感染患者早期诊断的价值[J].临床肝胆病杂志,2015,31(2):209-213.
Zheng JF,Cai ZH,Zhang X,et al.Value of single or combined measurement of serum PCT,peripheral WBC,and WBC/PLT for early diagnosis of bacterialinfection in patients with liver cirrhosis[J].J Clin Hepatol,2015,31(2):209-213.
[3] 刘 丹,朱清静,万十千,等.血清降钙素原联合C-反应蛋白检测诊断肝硬化并发自发性细菌性腹膜炎价值探讨[J].实用肝脏病杂志,2015,18(1):80-81.
Liu D,Zhu QJ,WAN SQ,et al.Application of serum procalction and C-reactive protein detection in diagnosis of patients with liver cirrhosis and spontaneous bacterial peritonitis[J].J Pras Hepatol,2015,18(1):80-81.
[4] Nanno S,Koh H,Katayama T,et al.Plasma levels of presepsin(Soluble CD14-subtype)as a novel prognostic marker for hemophagocytic syndrome in hematological malignancies[J].Intern Med,2016,55(16):2173-2184.
[5] 姚光弼.临床肝脏病学[M].2版.上海:上海科学技术出版社,2011.
Yao GB.Clinical Hepatology[M].2th Ed.Shanghai:Shanghai Scienceand Technology Press,2011.
[6] Mariani M,Zuccaro V,Patruno SF,et al.The impact of rifaximin in the prevention of bacterial infections in cirrhosis[J].Eur Rev Med Pharmacol Sci,2017,21(5):1151-1158.
[7] 张 蕾,王 勇,李华龙,等.乙型肝炎肝硬化伴上消化道出血患者医院感染因素分析[J].中华医院感染学杂志,2016,26(17):3903-3905.
Zhang L,Wang Y,Li HL,et al.Related factors for nosocomial infections in hepatitis B cirrhosis patients complicated with upper gastrointestinal bleeding[J].Chin J Nosocomiol,2016,26(17):3903-3905.
[8] Lin J,Li Z,Zheng Y,et al.Elevated presepsin levels are associated with severity and prognosis of severe acute pancreatitis[J].Clin Lab,2016,62(9):1699-1708.
[9] 陈义坤,赵 明,张 浩.脓毒症患者血浆Presepsin水平检测的临床意义[J].实用医学杂志,2014,30(20):3256-3258.
Chen YK,Zhao M,Zhang H.Clinical significance of presepsin level in patients with sepsis[J].The Journal of Practical Medicine,2014,30(20):3256-3258.
[10] Wu H,Chen L,Sun Y,et al.The role of serum procalcitonin andC-reactive protein levels in predicting spontaneous bacterial peritonitis in patients with advanced liver cirrhosis[J].Pak J Med Sci,2016,32(6):1484-1488.
[11] 袁平宗,汤雪彪,王小龙,等.革兰氏阴性细菌感染患者血清内毒素检测临床探讨[J].现代检验医学杂志,2016,31(6):121-123.
Yuan PZ,Tang XB,Wang XL,et al.Detection of serum endotoxin in patientswith gram negative bacterial infection[J].J Mod Lab Med,2016,31(6):121-123.
[12] Sargenti K,Prytz H,Strand A,et al.Healthcare-associated and nosocomial bacterial infections in cirrhosis:predictors and impact on outcome[J].Liver International,2015,35(2):391-400.
[13] Papp M,Tornai T,Vitalis Z,et al.Presepsin teardown-pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis[J].World J Gastroenterol,2016,22(41):9172-9185.
[14] Park,JK,Lee CH,Kin IH,et al.Clinical characteristics and prognosticimpact of bacterial infection in hospitalized patients with alcoholic liver disease[J].Journal of Korean Medical Science,2015,30(5):598-605.
[15] 景富春,张素梅,高 英,等.血清PCT与CRP检测在肝硬化并肺部感染患者诊治中的临床价值[J].检验医学与临床,2016,13(11):1457-1458,1461.
Jing FC,Zhang SM,Gao Y,et al.Clinical significance of detecting serumprocalcition and C reactive protein among hepatic cirrhosis patients with lung infection[J].Lab Med Clin,2016,13(11):1457-1458,1461.
[16] Kim IK,Park JS,Ju MK.Impact of pre-transplant bacterial infections on post-operative outcomes in patients after liver transplantation[J].Surg Infect,2017,18(2):170-175.
[17] Koizumi Y,Shimizu K,Shigeta M,et al.Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients[J].BMC Infect Dis,2017,17(1):27.
[18] Leli C,Ferranti M,Marrano U,et al.Diagnostic accuracy of presepsin(sCD14-ST)and procalcitonin for prediction of bacteraemia and bacterial DNA aemia in patients with suspected sepsis[J].J Med Microbiol,2016,65(8):713-719.
收稿日期:2017-03-17
修回日期:2017-09-24
相似文献/References:
[1]李 峰,魏 群,周国雄,等.髓样细胞白血病-1基因
在原发性肝癌组织中的表达及临床意义[J].现代检验医学杂志,2016,31(03):69.[doi:10.3969/j.issn.1671-7414.2016.03.019]
LI Feng,WEI Qun,ZHOU Guo-xiong,et al.Expression and Significance of Mcl-1 Gene in Hepatocellular Carcinoma[J].Journal of Modern Laboratory Medicine,2016,31(06):69.[doi:10.3969/j.issn.1671-7414.2016.03.019]
[2]薛顺和,袁东红,王 芳,等.肝硬化患者并发感染及死亡与肠道通透性实验检测的相关性研究[J].现代检验医学杂志,2017,32(01):95.[doi:10.3969/j.issn.1671-7414.2017.01.026]
XUE Shun-he,YUAN Dong-hong,WANG Fang,et al.Correlation between Liver Cirrhosis Patients Combined
with Infection or Death and Intestinal Permeability Test[J].Journal of Modern Laboratory Medicine,2017,32(06):95.[doi:10.3969/j.issn.1671-7414.2017.01.026]
[3]任雪维,张吉才.肝细胞肝癌患者血浆miR-29a水平的变化及其临床意义[J].现代检验医学杂志,2017,32(02):33.[doi:10.3969/j.issn.1671-7414.2017.02.009]
REN Xue-wei,ZHANG Ji-cai.Changes of Plasma miR-29a Levels in Patients
with Hepatocellular Carcinoma and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2017,32(06):33.[doi:10.3969/j.issn.1671-7414.2017.02.009]
[4]卓传尚,柳丽娟,周淑燕.AFP-L3和PIVKA-Ⅱ检测对高危人群良恶性肝病的鉴别诊断价值[J].现代检验医学杂志,2017,32(04):40.[doi:10.3969/j.issn.1671-7414.2017.04.011]
ZHUO Chuan-shang,LIU Li-juan,ZHOU Shu-yan.Performance of Serum AFP-L3 and PIVKA-Ⅱ in Differential Diagnosis
of Benign and Malignant Liver Disease in High Risk Population[J].Journal of Modern Laboratory Medicine,2017,32(06):40.[doi:10.3969/j.issn.1671-7414.2017.04.011]